Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Postoperative Pain in Laparoscopic Cholecystectomy
NCT06561438Phase 3Completed
- Sponsor
- Future University in Egypt
- Start
- Aug 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vortioxetine in postoperative pain (2 arms), sponsored by Future University in Egypt. Primary endpoint: Visual Analogue Scale at 24 hours. Started Aug 2024; status: completed.
02
Drugs
vortioxetine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06561438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06561438.